SOPH Share Price Performance
SOPH Community Fair Values
- US$7.25FV56.8% undervalued intrinsic discount23.19%Revenue growth p.a.0users have liked this narrative0users have commented on this narrative3users have followed this narrative9 days ago author updated this narrative
Recent SOPH News & Updates
No updates
SOPHiA GENETICS SA Key Details
Last Reported Earnings
Mar 31, 2025
Next Reporting Earnings
Aug 05, 2025
- Earnings per share (EPS)
- -0.99
- Gross Margin
- 68.09%
- Net Profit Margin
- -98.51%
- Debt/Equity Ratio
- 15.6%
SOPHiA GENETICS SA Competitors
About SOPH
- Founded
- 2011
- Employees
- 423
- CEO
- WebsiteView website
SOPHiA GENETICS SA operates as a cloud-native software technology company in the healthcare space. It offers SOPHiA DDM platform, a cloud-native software platform for analyzing data and generating insights from multimodal data sets and diagnostic modalities. Its SOPHiA DDM platform and related solutions, applications, products, and services are used by hospitals, laboratories, and biopharmaceutical companies through its own sales force as well as distributors and industry collaborators in Switzerland, France, Italy, rest of Europe, North America, the United States, Latin America, and the Asia-pacific. SOPHiA GENETICS SA was incorporated in 2011 and is based in Rolle, Switzerland.
Swiss Market Performance
- 7 Days: -1.9%
- 3 Months: -1.9%
- 1 Year: -2.7%
- Year to Date: 2.2%
Over the last 7 days, the market has dropped 1.9%, driven by a pullback of 1.9% in the Healthcare sector. In the last 12 months the market has been flat overall. Looking forward, earnings are forecast to grow by 11% annually. Market details ›
This week, we’re diving deeper into the world of agentic AI. We’re zeroing in on the core technologies that make these intelligent agents actually reliably work. We explore what all this could mean for software, start-ups, and most importantly, the opportunities and risks each industry faces by adopting Agentic AI.
Continue reading